Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × apatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 11 Stomach Neoplasms 6 Carcinoma, Non-Small-Cell Lung 3 Sarcoma 2 Ovarian Neoplasms 2 Liver Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Advanced Gastric Cancer 2 Adenocarcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Limited Stage 1 Small Cell Lung Cancer Extensive Stage 1 Salivary Gland Neoplasms 1 Radioactive Iodine-refractory Differentiated Thyroid Cancer 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Malignant Neoplasms of Digestive Organs 1 Gestational Trophoblastic Disease 1 Gastric Adenocarcinoma 1 Fludzoparib" and Anti-angiogenic 1 Colonic Neoplasms 1 Cirrhosis, Familial, with Pulmonary Hypertension 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Advanced Biliary Tract Carcinoma 1 Adrenocortical Carcinoma 1 Adrenal Gland Neoplasms 1 Adebrelimab 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡